2004European Journal of Clinical PharmacologyOpen access

Cytochrome P 450 2C9 phenotyping using low-dose tolbutamide

Alexander Jetter, Martina Kinzig‐Schippers, Andreas Skott, Andreas Lazar, Dorota Tomalik‐Scharte, Julia Kirchheiner, Monika Walchner‐Bonjean, Ursula Hering, Verena Jakob, Michael Rodamer, Wafa� Jabrane, Dirk Kasel, J�rgen Brockm�ller, Uwe Fuhr, F. S�rgel

Open full text 72 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 72 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Tolbutamide, CYP2C9, Pharmacokinetics, Urine, Chemistry, Internal medicine, Endocrinology, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Cytochrome P 450 2C9 phenotyping using low-dose tolbutamide — Research Paper | ScholarLens